October 13 - 14, 2020 | San Francisco, California
Monday, October 21, 2019 | 12:45 PM - 6:30 PM
The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.
The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties.
Participation in the BIO SPARK Showcase is free. Sign up here to register for the BIO SPARK Showcase.
2019 BIO SPARK Showcase Presentation Schedule
|
Time |
Spark Affiliate and Program |
|
12:45 PM - 12:50 PM
|
Welcome from SPARK Translational Research Program, Stanford Medicine
|
|
12:50 PM - 1:10 PM
|
SPARK at Stanford - Bacchus Therapeutics
Novel Treatment for Kidney Cancer Arvin Gouw |
|
1:10 PM - 1:30 PM
|
SPARK Japan - Metcela
Revolutionizing the way we treat heart failure Joon Paeck |
| 1:30 PM - 1:50 PM | SPARK Taiwan Selective Top2 Chemotherapies Tsai-Kun Li |
|
1:50 PM - 2:10 PM
|
SPARK Japan - CardioGas
Inhalation Therapy of Nitric Oxide and Hydrogen Gas for Acute Myocardial Infarction Kenichi Kokubo |
|
2:10 PM - 2:30 PM
|
SPARK Colorado
A Breakthrough Therapy for Triple-Negative Breast Cancer Jim Lambert |
|
2:30 PM - 2:40 PM
|
Break
|
|
2:40 PM - 3:00 PM
|
SPARK Japan - MiiBio
Gene engineering tools for optical control of CRISPR/Cas9·Cpf1, Cre-loxP system Kensho Hayamizu |
|
3:00 PM - 3:20 PM
|
SPARK Norway
A novel vaccine platform against influenza Gunnveig Grødeland |
|
3:20 PM - 3:40 PM
|
SPARK at Stanford
Small Molecule for the treatment of Type 1 Diabetes Andy Wardle |
|
3:40 PM - 4:00 PM
|
SPARK Germany
Recombinant human Neuregulin1 (rhNRG1) for the treatment of Schwann cell-‐derived nerve sheath tumors Sonja Schätzlein |
|
4:00 PM - 4:10 PM
|
Break
|
|
4:10 PM - 4:30 PM
|
SPARK Stanford - Rejuvenation Technologies
Transient telomere extension to treat liver failure in dyskeratosis congenita patients John Ramunas |
|
4:30 PM - 4:50 PM
|
SPARK Finland
Novel treatment modality for Limbal Epithelial Stem Cell Deficiency Laura Koivusalo |
|
4:50 PM - 5:10 PM
|
SPARK Norway
Repositioning of existing drugs to Prevent ventricular arrhythmias Jonas Skogestad |
|
5:10 PM - 5:30 PM
|
SPARK at Stanford
Charge-Altering Releasable Transporters (CARTS): New Materials enable a New Platform Technology for Gene Delivery, Vaccinations, and Cancer Immunotherapy Tim Blake |
|
5:30 PM - 5:50 PM
|
SPARK Australia (Monash University)- Regenasome Pty LTD
Developing amniotic exosomes for fibrosis and unmet medical needs Julian Vultaggio |
|
5:50 PM - 6:45 PM
|
Reception
|